Salient Surgical Technologies Newswire

Salient Surgical Technologies Newswire

Comprehensive Real-Time News Feed for Salient Surgical Technologies.

Results 1 - 20 of 662 in Salient Surgical Technologies

  1. Board member: DermSpectra to revolutionize skin careRead the original story

    Yesterday | UnionLeader.com

    A former U.S. Surgeon General says the technology developed by Digital Skin Imaging could revolutionize the way doctors approach treating diseases of the skin.

    Comment?

  2. Medtronic Announces FDA Approval and U.S. Launch of Next Generation...Read the original story

    Monday | PressReleasePoint

    The Intellis Platform Includes the World's Smallest Implantable Spinal Cord Stimulator and Offers Personalized Pain Relief and Advanced Activity Tracking DUBLIN - September 18, 2017 - Medtronic plc today announced FDA approval and U.S. launch of the Intellis platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation systems, such as battery performance, and can power the Evolve , which standardizes guidance and balances high-dose and low-dose therapy settings.

    Comment?

  3. Absolute Analysis on Cryotherapy and Cryosurgery Market: Valuation...Read the original story w/Photo

    Monday | SBWire

    Market Research Future published a Cooked research report on "Cryotherapy and Cryosurgery Market Research Report - Global Forecast to 2023" - Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023. Cryotherapy and cryosurgery market is developing respectably.

    Comment?

  4. Medtronic Wins FDA Nod and Launch of Next Generation Chronic Pain Spinal Cord StimulatorRead the original story

    Sunday Sep 17 | BioSpace

    September 18, 2017 - Medtronic plc today announced FDA approval and U.S. launch of the Intellis platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation systems, such as battery performance, and can power the EvolveSM workflow*, which standardizes guidance and balances high-dose and low-dose therapy settings.

    Comment?

  5. Global Endotracheal Tubes Market 2017- ConvaTec, Teleflex Medical, Bard Medical and MedtronicRead the original story w/Photo

    Friday Sep 15 | SBWire

    Furthermore it also cover-up forecast and analysis for Endotracheal Tubes market on the global and regional level. The report analyses Endotracheal Tubes market on basis of its attractiveness and investment feasibility.

    Comment?

  6. Medtronic PLC (MDT) Position Trimmed by Heritage Investors Management CorpRead the original story w/Photo

    Friday Sep 15 | Daily Political

    Heritage Investors Management Corp lessened its holdings in shares of Medtronic PLC by 4.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission . The firm owned 63,046 shares of the medical technology company's stock after selling 3,192 shares during the period.

    Comment?

  7. Spinal Trauma Devices Market: Future Market Projections for Forthcoming YearsRead the original story w/Photo

    Friday Sep 15 | SBWire

    The global spinal trauma devices market could reach a valuation of US$4.7 bn by 2023 at a 5.6% CAGR for the forecast timeframe 2015-2023. Internal fixation devices have been predicted to make the cut in the market with a higher CAGR of 6.1%.

    Comment?

  8. Medtronic Announces Inaugural 2017 Global Champions TeamRead the original story

    Thursday Sep 14 | BioSpace

    September 14, 2017 - Long distance running is never easy. But for twenty long-distance runners participating in the Medtronic Twin Cities Marathon Weekend, just toeing the starting line is a remarkable achievement.

    Comment?

  9. LivaNova to Explore Strategic Options for Cardiac Rhythm Management Business FranchiseRead the original story

    Thursday Sep 14 | Customer Interaction Solutions

    LivaNova PLC , a market-leading medical technology and innovation company, today announced it is exploring strategic options for its Cardiac Rhythm Management Business Franchise. "As part of our ongoing efforts to position LivaNova for long-term success, we are sharpening our focus on the Company's areas of strength and market leadership.

    Comment?

  10. Medtronic PLC (MDT) Stock Rating Lowered by Zacks Investment ResearchRead the original story w/Photo

    Wednesday Sep 13 | IntersportsWire

    According to Zacks, "Over the last three months, Medtronic has been observed to underperform the broader industry. We note that, escalating costs and expenses are weighing on margins.

    Comment?

  11. New Five-Year Gender Subset Data from the Medtronic Engage Registry...Read the original story

    Wednesday Sep 13 | GlobeNewswire

    September 13, 2017 - Medtronic plc today reported its EndurantA II abdominal aortic aneurysm stent graft system continues to demonstrate long-term durability and consistent outcomes in a real-world setting among both male and female patients. The five-year ENGAGE global registry data were presented for the first time by Marc Schermerhorn, M.D., chief, division of vascular and endovascular surgery, Beth Israel Deaconess Medical Center, Boston, Mass., in a late-breaking clinical trial at the Vascular Interventional Advances 2017 conference in Las Vegas.

    Comment?

  12. North America Glucose Monitoring Devices Market | Size | ShareRead the original story

    Wednesday Sep 13 | Emailwire.com

    The North America Glucose Monitoring Device Market is very fast growing market and expected to reach $767.1 million by 2021 from $585.82 million in 2016, at a CAGR of 5.54% from 2016-2021. The North America rules the glucose monitoring device market with the highest market value and a share of 34% in the global market in the year 2016.

    Comment?

  13. Medtronic in.Pact Admiral DCB Global Two Year Data And in.Pact Sfa...Read the original story

    Tuesday Sep 12 | BioSpace

    September 12, 2017 - Medtronic plc data announced today reinforce the durability and safety of the IN.PACT Admiral drug-coated balloon in patients with peripheral arterial disease . The two-year, real-world results from the full clinical cohort of the IN.PACT Global Study and four-year results from the pivotal IN.PACT SFA Study were presented in two late-breaking clinical trial presentations at the Vascular Interventional Advances 2017 conference in Las Vegas.

    Comment?

  14. Bbva Compass Bancshares Inc. Has $8.32 Million Position in Medtronic PLCRead the original story w/Photo

    Wednesday Sep 13 | IntersportsWire

    Bbva Compass Bancshares Inc. boosted its stake in Medtronic PLC by 15.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 93,682 shares of the medical technology company's stock after buying an additional 12,480 shares during the quarter.

    Comment?

  15. North America Veterinary Surgical Devices Market poised to reach USD 383.08 million by 2021Read the original story w/Photo

    Tuesday Sep 12 | PR-inside.com

    Regional and country-level analysis and forecasts of the North America Veterinary Surgical Devices Market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions those are still untapped According to the report "North America Veterinary Surgical Devices Market By Products , By Animals , By Application , And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts " published by Market Data Forecast, the North America Veterinary Surgical Devices Market was worth USD 284.24 million in 2016 and estimated to be growing at a CAGR of 6.15%, to reach USD 383.08 million by 2021.

    Comment?

  16. North America Glucose Monitoring Devices MarketRead the original story w/Photo

    Tuesday Sep 12 | PR-inside.com

    The North America Glucose Monitoring Device Market is very fast growing market and expected to reach $767.1 million by 2021 from $585.82 million in 2016, at a CAGR of 5.54% from 2016-2021. The North America rules the glucose monitoring device market with the highest market value and a share of 34% in the global market in the year 2016.

    Comment?

  17. Medtronic Announces Voluntary Recall of Diabetes Infusion SetsRead the original story w/Photo

    Tuesday Sep 12 | US Recall News

    Medtronic plc announced today that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all models of Medtronic insulin pumps. The recall is related to a certain discontinued component in these infusion sets and does not include insulin pumps or glucose sensors.

    Comment?

  18. Xact Kapitalforvaltning AB Has $19.71 Million Holdings in Medtronic PLCRead the original story w/Photo

    Tuesday Sep 12 | The Breeze

    Xact Kapitalforvaltning AB lessened its holdings in shares of Medtronic PLC by 0.1% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 222,053 shares of the medical technology company's stock after selling 114 shares during the period.

    Comment?

  19. Medtronic Announces New StealthStation(TM) Technology for Ear, Nose, and Throat ProceduresRead the original story w/Photo

    Tuesday Sep 12 | PR-inside.com

    September 12, 2017 - Medtronic plc today announced the global launch of the StealthStation ENT, a new surgical navigation system designed for surgeons treating conditions within the ear, nose, and throat anatomy. The company has received U.S. Food and Drug Administration 510k clearance and CE Mark for the system.

    Comment?

  20. Medtronic recalls diabetes infusion sets for overdose riskRead the original story w/Photo

    Monday Sep 11 | Boston.com

    Medtronic Plc is recalling a disposable device used with the company's insulin pumps, after discovering that the part can trigger an excessive dose of the drug and put patients at risk of hypoglycemia. About one in every 2 million infusion sets manufactured before April may be associated with the complication, which occurs when a membrane that's used to release pressure from inside the pump gets wet and blocks the vents, said Francine Kaufman, chief medical officer of Medtronic's diabetes group.

    Comment?